Latest Market News

Resouro Strategic Metals has unveiled a robust Preliminary Economic Assessment for its Tiros Titanium and Rare Earths Project, signalling a post-tax NPV of US$715 million and a 44.2% IRR over 20 years. Meanwhile, binding agreements for mining and processing at the Novo Mundo Gold Project promise to unlock additional value.

Smartshares Limited’s annual report for the year ending 31 March 2026 details mixed fund unit movements, notable management changes, and key investment manager transitions within its suite of Exchange Traded Funds.

Burger Fuel Group posted a 92% surge in net profit to NZ$1.97 million for FY26, driven by steady system sales growth, a one-off store sale gain, and reduced legal expenses, while geopolitical instability in the Middle East weighs on international sales.

Imugene Limited reports a complete response in the first patient treated with azer-cel combined with BTK inhibitors in its Phase 1b trial, highlighting potential for resistant follicular lymphoma.

Aroa Biosurgery delivered a breakout FY26 with NZ$104 million revenue, driven by strong Myriad sales and clinical trial success, setting the stage for ambitious FY27 growth.

Brazilian Critical Minerals releases a robust Bankable Feasibility Study for its Ema Rare Earth Project, highlighting a US$1.47 billion post-tax NPV and a swift 0.5-year payback period, underpinned by low capital and operating costs.

EV Resources has verified continuous high-grade antimony mineralisation reaching 25.2% Sb at its Los Lirios Antimony Project through systematic underground channel sampling, underpinning plans for a maiden JORC Resource by year-end.

Cauldron Energy has updated its Yanrey Uranium Project exploration target, expanding the prospective uranium resource range to between 89.7 and 269 million pounds of uranium oxide, excluding its existing 55 million pounds resource base.

Peel Mining has distributed all shares in Spectre Metals to its shareholders, marking the completion of the demerger. This comes just before Aeris Resources is set to acquire Peel in a scheme of arrangement.

Euro Manganese has filed comprehensive NI 43-101 and JORC reports for its Chvaletice Manganese Project, confirming robust economics with a base case post-tax NPV of US$492 million and an upside scenario pushing NPV to US$798 million, driven by higher manganese prices.

Vanguard Investments Australia has released estimated distribution amounts for 34 ETFs, covering a broad spectrum of asset classes, with payments scheduled for mid-July 2026.

Saluda Medical has obtained FDA approval for its CAP24 surgical paddle lead, a first-of-its-kind device designed for closed-loop spinal cord stimulation, poised to broaden its US market reach and engage new surgical specialties.